Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

Resources & DevelopmentAGC Pharma Chemicals Announces Expansion of HPAPI Capabilities in Barcelona
29th January 2025

AGC Pharma Chemicals Announces Expansion of HPAPI Capabilities in Barcelona

Barcelona, 29th January 2025 – AGC Pharma Chemicals, a leading innovator in pharmaceutical manufacturing with over 40 years of expertise in Contract Development Manufacturing Operations (CDMO) for small molecule APIs…
Resources & DevelopmentAGC Pharma Chemicals: First and Only CDMO in Spain Recognized as a Top Employer for Excellence in People Management
22nd January 2025

AGC Pharma Chemicals: First and Only CDMO in Spain Recognized as a Top Employer for Excellence in People Management

Barcelona, 22nd January 2025 – AGC Pharma Chemicals, an international Contract Development and Manufacturing Organization (CDMO) with headquarters in Malgrat de Mar (Barcelona) and Japan, has been recognized as a…
Events & ConventionsAGC Pharma Chemicals at BOS Manchester 2024
12th November 2024

AGC Pharma Chemicals at BOS Manchester 2024

We are thrilled to announce our participation in BOS (Biotech Outsourcing Strategies) Manchester 2024, November 26-27.   BOS Manchester 2024's scope is primarily development stage CMC outsourcing for both Small Molecules…